L Reisin
Overview
Explore the profile of L Reisin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yosefy C, Hay E, Nasri Y, Magen E, Reisin L
Emerg Med J
. 2004 Aug;
21(5):557-9.
PMID: 15333528
Objectives: Patients arriving in the emergency department (ED) need rapid and reliable evaluation of their respiratory status. Mainstream end tidal carbon dioxide (ETCO(2)) is one of the methods used for...
2.
Yosefy C, Khalamizer V, Viskoper J, Iaina A, Manevich I, London D, et al.
Br J Biomed Sci
. 2003 Oct;
60(3):144-8.
PMID: 14560790
The offspring of coronary heart disease (CHD) patients are at particularly high risk for developing CHD. Endothelial dysfunction is present in the majority of CHD and atherosclerosis patients. Fish oil,...
3.
Bilateral posterior segment intraocular hemorrhage in a diabetic patients after therapy with heparin
Levartovsky S, Reisin I, Reisin L, Leibowitz E
Isr Med Assoc J
. 2003 Aug;
5(8):605.
PMID: 12929308
No abstract available.
4.
Levartovsky S, Reisin I, Reisin L, Leibowitz E
Isr Med Assoc J
. 2003 Feb;
5(1):77.
PMID: 12592970
No abstract available.
5.
Cotter G, Kiowski W, Kaluski E, Kobrin I, Milovanov O, Marmor A, et al.
Eur J Heart Fail
. 2001 Aug;
3(4):457-61.
PMID: 11511432
Objective: This study investigated the effect of tezosentan (an intravenous endothelin-1 receptor antagonist) on vascular resistance and cardiac function and determined the dose response in patients with stable congestive heart...
6.
Schalcher C, Cotter G, Reisin L, Bertel O, Kobrin I, Guyene T, et al.
Am Heart J
. 2001 Aug;
142(2):340-9.
PMID: 11479476
Background: Endothelin-1, a potent vasoconstrictor, is elevated in congestive heart failure and is postulated to play a major role in the pathogenesis of the disease. Endothelin receptor antagonism may be...
7.
Tzivoni D, Gilula Z, Klutstein M, Reisin L, Botvin S, Kobrin I
Cardiovasc Drugs Ther
. 2000 Dec;
14(5):503-9.
PMID: 11101198
Myocardial ischemia during daily life can be induced by increased demand and by increased coronary tone. The purpose of this study was to assess the mechanism of action of mibefradil,...
8.
Reisin L, Yosefy C, Kleir S, Hay E, Peled R, Scharf S
Harefuah
. 2000 Jul;
135(12):584-8, 655.
PMID: 10911487
Ischemic heart disease (IHD) is women is characterized by a higher morbidity and mortality in the peri-infarction and coronary bypass peri-operative periods. These epidemiological data strengthen our impression that the...
9.
Yosefy C, Linov L, Viskoper J, Hay E, Jafari J, Nasri Y, et al.
J Hum Hypertens
. 1999 Dec;
13(11):765-9.
PMID: 10578221
Blood pressure (BP) reduction of 5-6 mm Hg reduces the relative risk of stroke by 30-40%. This effect does not appear to depend on the antihypertensive agent used to bring...
10.
Somberg J, Yelamanchi V, Molnar J, Aschermann M, Bernink P, Caspi A, et al.
Am J Ther
. 1999 Jul;
4(11-12):401-4.
PMID: 10423637
Prostaglandin E ( 1 ) (PGE ( 1 ) ), the active ingredient of the drug alprostadil-alpha-cyclodextrin, has been effective in mitigating the clinical manifestations of peripheral arterial occlusive disease...